Keros Therapeutics, Inc. (KROS) — Shares Outstanding

Annual figures by fiscal year, from SEC filings.

2019: 2.43M2020: 23.19M2021: 23.97M2022: 27.54M2023: 31.84M2024: 40.55M2025: 19.54M19.54M
2019Shares Outstanding (shares)2025
Fiscal YearShares OutstandingChange YoY
202519.54M-51.8%
202440.55M+27.4%
202331.84M+15.6%
202227.54M+14.9%
202123.97M+3.4%
202023.19M+854.6%
20192.43M